Scholars@Duke

Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.

Publication ,  Journal Article
Gurbel, PA; Tantry, US
Published in: Heart
June 1, 2016
Published version (DOI) Link to item

Duke Scholars

Paul Alfred Gurbel
Author Paul Alfred Gurbel Medicine, Clinical Pharmacology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Heart

DOI

10.1136/heartjnl-2014-306695

EISSN

1468-201X

Publication Date

June 1, 2016

Volume

102

Issue

11

Start / End Page

882 / 892

Location

England

Related Subject Headings

  • Treatment Outcome
  • Risk Factors
  • Platelet Aggregation Inhibitors
  • Non-ST Elevated Myocardial Infarction
  • Humans
  • Hemorrhage
  • Fibrinolytic Agents
  • Cardiovascular System & Hematology
  • Blood Coagulation
  • Anticoagulants
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., & Tantry, U. S. (2016). Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes. Heart, 102(11), 882–892. https://doi.org/10.1136/heartjnl-2014-306695
Gurbel, Paul A., and Udaya S. Tantry. “Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.” Heart 102, no. 11 (June 1, 2016): 882–92. https://doi.org/10.1136/heartjnl-2014-306695.
Gurbel, Paul A., and Udaya S. Tantry. “Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.” Heart, vol. 102, no. 11, June 2016, pp. 882–92. Pubmed, doi:10.1136/heartjnl-2014-306695.

Published In

Heart

DOI

10.1136/heartjnl-2014-306695

EISSN

1468-201X

Publication Date

June 1, 2016

Volume

102

Issue

11

Start / End Page

882 / 892

Location

England

Related Subject Headings

  • Treatment Outcome
  • Risk Factors
  • Platelet Aggregation Inhibitors
  • Non-ST Elevated Myocardial Infarction
  • Humans
  • Hemorrhage
  • Fibrinolytic Agents
  • Cardiovascular System & Hematology
  • Blood Coagulation
  • Anticoagulants